Anja M. van der Laan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anja M. van der Laan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Connor Lantz
Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
1 shared publication - Daniel J. Brat
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
1 shared publication - David P. Sullivan
Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
1 shared publication - Edward Benjamin Thorp
Northwestern University Feinberg School of Medicine
1 shared publication - Hans W. M. Niessen
Department of Pathology and Department of Cardiac Surgery, Institute for Cardiovascular Research, Amsterdam University Medical Center, 1007 MB Amsterdam, Netherlands
1 shared publication - Lisa D. Wilsbacher
Northwestern University Feinberg School of Medicine, Simpson Querrey Biomedical Research Center 8-404, 303 E. Superior St., Chicago, IL 60611, USA
1 shared publication
Latest Publications
- Open Access
- 29 July 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (9)
Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair
Hypoxia-inducible factors (HIFs) are activated in parenchymal cells in response to low oxygen and as such have been proposed as therapeutic targets during hypoxic insult, including myocardial infarction (MI). HIFs are also activated within macrophages, which orchestrate the tissue repair response. Although isoform-specific therapeutics are in development for cardiac ischemic injury, surprisingly, the unique role of myeloid HIFs, and particularly HIF-2α, is unknown. Using a murine model of myocardial infarction and mice with conditional genetic loss and gain of function, we uncovered unique proinflammatory roles for myeloid cell expression of HIF-1α and HIF-2α during MI. We found that HIF-2α suppressed anti-inflammatory macrophage mitochondrial metabolism, while HIF-1α promoted cleavage of cardioprotective MerTK through glycolytic reprogramming of macrophages. Unexpectedly, combinatorial loss of both myeloid HIF-1α and HIF-2α was catastrophic and led to macrophage necroptosis, impaired fibrogenesis, and cardiac rupture. These findings support a strategy for selective inhibition of macrophage HIF isoforms and promotion of anti-inflammatory mitochondrial metabolism during ischemic tissue repair.
- 29 July 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (9)
Open AccessHypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair
Hypoxia-inducible factors (HIFs) are activated in parenchymal cells in response to low oxygen and as such have been proposed as therapeutic targets during hypoxic insult, including myocardial infarction (MI). HIFs are also activated within macrophages, which orchestrate the tissue repair response. Although isoform-specific therapeutics are in development for cardiac ischemic injury, surprisingly, the unique role of myeloid HIFs, and particularly HIF-2α, is unknown. Using a murine model of myocardial infarction and mice with conditional genetic loss and gain of function, we uncovered unique proinflammatory roles for myeloid cell expression of HIF-1α and HIF-2α during MI. We found that HIF-2α suppressed anti-inflammatory macrophage mitochondrial metabolism, while HIF-1α promoted cleavage of cardioprotective MerTK through glycolytic reprogramming of macrophages. Unexpectedly, combinatorial loss of both myeloid HIF-1α and HIF-2α was catastrophic and led to macrophage necroptosis, impaired fibrogenesis, and cardiac rupture. These findings support a strategy for selective inhibition of macrophage HIF isoforms and promotion of anti-inflammatory mitochondrial metabolism during ischemic tissue repair.